APTEVO THERAPEUTICS INC (APVO) Forecast, Price Target & Analyst Ratings
NASDAQ:APVO • US03835L7029
5.49 USD
-1.25 (-18.55%)
Last: Mar 10, 2026, 10:38 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APTEVO THERAPEUTICS INC (APVO).
Forecast Snapshot
Consensus Price Target
$7,711.20
+ 140,359.02% Upside
Next Earnings Forecast
Release DateMay 12, 2026
PeriodQ4 / 2025
EPS Estimate-$8.26
Revenue Estimate
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$7,711.20
Upside
+ 140,359.02%
From current price of $5.49 to mean target of $7,711.20, Based on 7 analyst forecasts
Low
$7,635.60
Median
$7,711.20
High
$7,938.00
Price Target Revisions
1 Month
0.00%
3 Months
1,700.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for APVO. The average price target is 7711.2 USD. This implies a price increase of 140359.02% is expected in the next year compared to the current price of 5.49.
The average price target has been revised upward by 1700% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
APVO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about APVO.
In the previous month the buy percentage consensus was at a similar level.
APVO was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-09-23 | Roth MKM | Maintains | Buy -> Buy |
| 2022-05-13 | Piper Sandler | Maintains | Overweight |
| 2021-05-28 | Roth Capital | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 12, 2026
PeriodQ4 / 2025
EPS Estimate-$8.26
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q99.50%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-1,700.00%
Next Earnings Summary
APVO is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -8.26 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.309M | 12.292M 185.26% | 3.114M -74.67% | -100.00% | 24.568M | 75.361M 206.74% | 115.61M 53.41% | 153.76M 33.00% | ||||||
| EBITDA YoY % growth | -26.088M 32.64% | -20.256M 22.36% | -27.74M -36.95% | N/A -2.06% | N/A 12.94% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -27.494M 32.88% | -21.4M 22.16% | -28.641M -33.84% | -29.808M -0.83% | -23.907M 13.43% | -28.493M -13.97% | -28.93M -1.54% | -29.377M -1.54% | -29.83M -1.54% | -5.072M 83.00% | 45.903M 1,004.95% | 86.333M 88.08% | 124.65M 44.38% | |
| Operating Margin | -638.06% | -174.10% | -919.75% | N/A | N/A | N/A | N/A | N/A | N/A | -20.65% | 60.91% | 74.68% | 81.07% | |
| EPS YoY % growth | -291,737.60 43.86% | -198,290.40 32.03% | 51,444.80 125.94% | -1,025,229.74 -193.67% | -31,564.51 78.00% | -98.78 99.07% | -29.38 70.26% | -28.46 3.13% | -1.53 94.62% | -4.41 -188.00% | 24.24 650.00% | 44.06 81.82% | 55.81 26.67% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -8.26 99.50% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -7.77M -21.75% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.94%
EPS Next 5 Year
14.87%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
APTEVO THERAPEUTICS INC / APVO Forecast FAQ
What is the price target for APVO stock?
7 analysts have analysed APVO and the average price target is 7711.2 USD. This implies a price increase of 140359.02% is expected in the next year compared to the current price of 5.49.
When does APTEVO THERAPEUTICS INC (APVO) report earnings?
APTEVO THERAPEUTICS INC (APVO) will report earnings on 2026-05-12.
What are the consensus estimates for APTEVO THERAPEUTICS INC (APVO) next earnings?
The consensus EPS estimate for the next earnings of APTEVO THERAPEUTICS INC (APVO) is -8.26 USD and the consensus revenue estimate is 0 USD.